PharmiWeb13h
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...
PharmiWeb3h
tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – ...
PharmiWeb4m
PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
PharmiWeb4m
uniQure Announces Pricing of its Public Offering
Qure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its underwritten public offering of 4 ...
PharmiWeb3h
Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences
Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...
PharmiWeb9m
iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Teos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today ...
PharmiWeb22m
Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and its commercialization partner Fresenius Kabi announce that Health Canada has issued a “Notice of Compliance” (NOC) ...
PharmiWeb11m
"Annotatability" is a New Method to Decode How AI Learns to Label Developed by Hebrew University Researchers
A powerful, new framework called "Annotatability" has been developed by researchers at the Hebrew University of Jerusalem to address a major challenge in biological research -- identifying mismatches ...
PharmiWeb56m
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding ...
PharmiWeb56m
TriageLogic Launches TriageIntelligence(TM) and Releases Updated Nurse Triage Handbook
JACKSONVILLE, FLORIDA / ACCESSWIRE / January 8, 2025 / TriageLogic, a leader in telehealth triage solutions, has announced two major advancements for 2024: the launch of TriageIntelligence™, an ...
PharmiWeb2h
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are ...
PharmiWeb2h
Cambridge Cognition highlights positive CANTAB® results in research by Bristol Myers Squib
Cambridge Cognition Holdings plc (AIM: COG), the brain health software group, congratulates Bristol Myers Squibb, the global biopharmaceutical company, for its recent FDA approval of Cobenfy (KarXT™ ...